The DOI matches its Crossref record; 63 of the 63 references it cites were found in a registry or an index.
Identification of chemically diverse Chk1 inhibitors by receptor-based virtual screening
Open accessOverview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Berman, H. M. (2000) · Nucleic Acids Research · doi:10.1093/nar/28.1.235 · Cited by 40,196
All-Atom Empirical Potential for Molecular Modeling and Dynamics Studies of Proteins
MacKerell, A. D., Bashford, D., Bellott, M., Dunbrack, R. L., Evanseck, J. D., Field, M. J., Fischer, S., Gao, J., Guo, H., Ha, S., et al. (1998) · The Journal of Physical Chemistry B · doi:10.1021/jp973084f · Cited by 14,311
Lipinski, C. A., Lombardo, F., Dominy, B. W., & Feeney, P. J. (1997) · Advanced Drug Delivery Reviews · doi:10.1016/s0169-409x(96)00423-1 · Cited by 11,385
Friesner, R. A., Banks, J. L., Murphy, R. B., Halgren, T. A., Klicic, J. J., Mainz, D. T., Repasky, M. P., Knoll, E. H., Shelley, M., Perry, J. K., et al. (2004) · Journal of Medicinal Chemistry · doi:10.1021/jm0306430 · Cited by 10,057
Merck molecular force field. I. Basis, form, scope, parameterization, and performance of MMFF94
Halgren, T. A. (1996) · Journal of Computational Chemistry · doi:10.1002/(sici)1096-987x(199604)17:5/6<490::aid-jcc1>3.0.co;2-p · Cited by 5,306
Docking and scoring in virtual screening for drug discovery: methods and applications
Kitchen, D. B., Decornez, H., Furr, J. R., & Bajorath, J. (2004) · Nature Reviews Drug Discovery · doi:10.1038/nrd1549 · Cited by 4,150
Molecular recognition of receptor sites using a genetic algorithm with a description of desolvation
Jones, G., Willett, P., & Glen, R. C. (1995) · Journal of Molecular Biology · doi:10.1016/s0022-2836(95)80037-9 · Cited by 1,546
Prediction of Physicochemical Parameters by Atomic Contributions
Wildman, S. A., & Crippen, G. M. (1999) · Journal of Chemical Information and Computer Sciences · doi:10.1021/ci990307l · Cited by 1,464
Sanchez, Y., Wong, C., Thoma, R. S., Richman, R., Wu, Z., Piwnica-Worms, H., & Elledge, S. J. (1997) · Science · doi:10.1126/science.277.5331.1497 · Cited by 1,320
Protein Kinase Inhibitors: Insights into Drug Design from Structure
Noble, M. E. M., Endicott, J. A., & Johnson, L. N. (2004) · Science · doi:10.1126/science.1095920 · Cited by 1,198
Evaluation of the FLEXX incremental construction algorithm for protein-ligand docking
Kramer, B., Rarey, M., & Lengauer, T. (1999) · Proteins: Structure, Function, and Genetics · doi:10.1002/(sici)1097-0134(19991101)37:2<228::aid-prot8>3.0.co;2-8 · Cited by 906
Molecular Complexity and Its Impact on the Probability of Finding Leads for Drug Discovery
Hann, M. M., Leach, A. R., & Harper, G. (2001) · Journal of Chemical Information and Computer Sciences · doi:10.1021/ci000403i · Cited by 877
Is There a Difference between Leads and Drugs? A Historical Perspective
Oprea, T. I., Davis, A. M., Teague, S. J., & Leeson, P. D. (2001) · Journal of Chemical Information and Computer Sciences · doi:10.1021/ci010366a · Cited by 769
A Comprehensive Listing of Bioactivation Pathways of Organic Functional Groups
Kalgutkar, A., Gardner, I., Obach, R., Shaffer, C., Callegari, E., Henne, K., Mutlib, A., Dalvie, D., Lee, J., Nakai, Y., et al. (2005) · Current Drug Metabolism · doi:10.2174/1389200054021799 · Cited by 616
Russom, C. L., Bradbury, S. P., Broderius, S. J., Hammermeister, D. E., & Drummond, R. A. (1997) · Environmental Toxicology and Chemistry · doi:10.1002/etc.5620160514 · Cited by 562
Graves, P. R., Yu, L., Schwarz, J. K., Gales, J., Sausville, E. A., O'Connor, P. M., & Piwnica-Worms, H. (2000) · Journal of Biological Chemistry · doi:10.1074/jbc.275.8.5600 · Cited by 544
Cdc25 Mitotic Inducer Targeted by Chk1 DNA Damage Checkpoint Kinase
Furnari, B., Rhind, N., & Russell, P. (1997) · Science · doi:10.1126/science.277.5331.1495 · Cited by 539
Automatic generation of 3D-atomic coordinates for organic molecules
Gasteiger, J., Rudolph, C., & Sadowski, J. (1990) · Tetrahedron Computer Methodology · doi:10.1016/0898-5529(90)90156-3 · Cited by 511
A unified view of the DNA-damage checkpoint
Melo, J., & Toczyski, D. (2002) · Current Opinion in Cell Biology · doi:10.1016/s0955-0674(02)00312-5 · Cited by 457
Perola, E., & Charifson, P. S. (2004) · Journal of Medicinal Chemistry · doi:10.1021/jm030563w · Cited by 447
A new test set for validating predictions of protein–ligand interaction
Nissink, J. W. M., Murray, C., Hartshorn, M., Verdonk, M. L., Cole, J. C., & Taylor, R. (2002) · Proteins: Structure, Function, and Bioinformatics · doi:10.1002/prot.10232 · Cited by 425
Why do we need so many chemical similarity search methods?
Sheridan, R. (2002) · Drug Discovery Today · doi:10.1016/s1359-6446(02)02411-x · Cited by 412
Virtual screening and fast automated docking methods
Schneider, G., & Böhm, H.-J. (2002) · Drug Discovery Today · doi:10.1016/s1359-6446(01)02091-8 · Cited by 404
A genetic algorithm for flexible molecular overlay and pharmacophore elucidation
Jones, G., Willett, P., & Glen, R. C. (1995) · Journal of Computer-Aided Molecular Design · doi:10.1007/bf00124324 · Cited by 390
Nonleadlikeness and leadlikeness in biochemical screening
Rishton, G. M. (2003) · Drug Discovery Today · doi:10.1016/s1359644602025722 · Cited by 381
G2 checkpoint abrogators as anticancer drugs
Kawabe, T. (2004) · Molecular Cancer Therapeutics · doi:10.1158/1535-7163.513.3.4 · Cited by 377
High-throughput docking for lead generation
Abagyan, R., & Totrov, M. (2001) · Current Opinion in Chemical Biology · doi:10.1016/s1367-5931(00)00217-9 · Cited by 343
Hydrogen Bonding, Hydrophobic Interactions, and Failure of the Rigid Receptor Hypothesis
Davis, A. M., & Teague, S. J. (1999) · Angewandte Chemie International Edition · doi:10.1002/(sici)1521-3773(19990315)38:6<736::aid-anie736>3.0.co;2-r · Cited by 333
Structure-Based Discovery of Inhibitors of Thymidylate Synthase
Shoichet, B. K., Stroud, R. M., Santi, D. V., Kuntz, I. D., & Perry, K. M. (1993) · Science · doi:10.1126/science.8451640 · Cited by 322
Chemical Inhibitors of Protein Kinases
Bridges, A. J. (2001) · Chemical Reviews · doi:10.1021/cr000250y · Cited by 320
(2000) · PubMed · Cited by 314
Phase I Trial of 72-Hour Continuous Infusion UCN-01 in Patients With Refractory Neoplasms
Sausville, E. A., Arbuck, S. G., Messmann, R., Headlee, D., Bauer, K. S., Lush, R. M., Murgo, A., Figg, W. D., Lahusen, T., Jaken, S., et al. (2001) · Journal of Clinical Oncology · doi:10.1200/jco.2001.19.8.2319 · Cited by 291
DesJarlais, R. L., Seibel, G. L., Kuntz, I. D., Furth, P. S., Alvarez, J. C., Ortiz de Montellano, P. R., DeCamp, D. L., Babé, L. M., & Craik, C. S. (1990) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.87.17.6644 · Cited by 253
Chk1-deficient tumour cells are viable but exhibit multiple checkpoint and survival defects
Zachos, G. (2003) · The EMBO Journal · doi:10.1093/emboj/cdg060 · Cited by 246
Jackson, J. R., Gilmartin, A. G., Imburgia, C. S., Winkler, J. D., Marshall, L. A., & Roshak, A. (2000) · PubMed · Cited by 229
Kinase inhibitors and the case for CH…O hydrogen bonds in protein–ligand binding
Pierce, A. C., Sandretto, K. L., & Bemis, G. W. (2002) · Proteins: Structure, Function, and Bioinformatics · doi:10.1002/prot.10259 · Cited by 225
Chk1 and Cds1: linchpins of the DNA damage and replication checkpoint pathways
Rhind, N., & Russell, P. (2000) · Journal of Cell Science · doi:10.1242/jcs.113.22.3889 · Cited by 219
Structural Basis for Chk1 Inhibition by UCN-01
Zhao, B., Bower, M. J., McDevitt, P. J., Zhao, H., Davis, S. T., Johanson, K. O., Green, S. M., Concha, N. O., & Zhou, B.-B. S. (2002) · Journal of Biological Chemistry · doi:10.1074/jbc.m201233200 · Cited by 206
Chen, P., Luo, C., Deng, Y., Ryan, K., Register, J., Margosiak, S., Tempczyk-Russell, A., Nguyen, B., Myers, P., Lundgren, K., et al. (2000) · Cell · doi:10.1016/s0092-8674(00)80704-7 · Cited by 196
Flexible Alignment of Small Molecules
Labute, P., Williams, C., Feher, M., Sourial, E., & Schmidt, J. M. (2001) · Journal of Medicinal Chemistry · doi:10.1021/jm0002634 · Cited by 192
Validation of an empirical RNA-ligand scoring function for fast flexible docking using RiboDock®
Morley, S. D., & Afshar, M. (2004) · Journal of Computer-Aided Molecular Design · doi:10.1023/b:jcam.0000035199.48747.1e · Cited by 178
The Structure-Based Design of ATP-Site Directed Protein Kinase Inhibitors
Toledo, Lydon, N. B., & Elbaum, D. (1999) · Current Medicinal Chemistry · doi:10.2174/092986730609220401150028 · Cited by 176
Grüneberg, S., Stubbs, M. T., & Klebe, G. (2002) · Journal of Medicinal Chemistry · doi:10.1021/jm011112j · Cited by 172
Novel technologies for virtual screening
Lengauer, T., Lemmen, C., Rarey, M., & Zimmermann, M. (2004) · Drug Discovery Today · doi:10.1016/s1359-6446(04)02939-3 · Cited by 168
Lopez‐Girona, A., Tanaka, K., Chen, X.-B., Baber, B. A., McGowan, C. H., & Russell, P. R. (2001) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.191557598 · Cited by 135
Kohn, E. A., Yoo, C. J., & Eastman, A. R. (2003) · PubMed · Cited by 128
Curman, D., Cinel, B., Williams, D. E., Rundle, N. T., Block, W. D., Goodarzi, A. A., Hutchins, J. R. A., Clarke, P. R., Zhou, B.-B., Lees‐Miller, S. P., et al. (2001) · Journal of Biological Chemistry · doi:10.1074/jbc.m100728200 · Cited by 121
Senderowicz, A. M. (2002) · The Oncologist · doi:10.1634/theoncologist.7-suppl_3-12 · Cited by 119
Baurin, N., Baker, R., Richardson, C., Chen, I., Foloppe, N., Potter, A., Jordan, A. M., Roughley, S. D., Parratt, M. J., Greaney, P., et al. (2004) · Journal of Chemical Information and Computer Sciences · doi:10.1021/ci034260m · Cited by 119
Self-citationLyne, P. D., Kenny, P. W., Cosgrove, D. A., Deng, C., Zabludoff, S., Wendoloski, J. J., & Ashwell, S. (2004) · Journal of Medicinal Chemistry · doi:10.1021/jm030504i · Cited by 113
Structural biology in drug design: selective protein kinase inhibitors
Scapin, G. (2002) · Drug Discovery Today · doi:10.1016/s1359-6446(02)02290-0 · Cited by 107
Foloppe, N., Fisher, L. M., Howes, R., Kierstan, P., Potter, A. J., Robertson, A., & Surgenor, A. E. (2005) · Journal of Medicinal Chemistry · doi:10.1021/jm049022c · Cited by 96
Self-citationRoberge, M., Berlinck, R. G. S., Xu, L., Anderson, H. J., Lim, L. Y., Curman, D., Stringer, C. M., Friend, S. H., Davies, P., Vincent, I. J., et al. (1998) · PubMed · Cited by 91
Chemical substructures in drug discovery
Merlot, C., Domine, D., Cleva, C., & Church, D. J. (2003) · Drug Discovery Today · doi:10.1016/s1359-6446(03)02740-5 · Cited by 78
Polgár, T., Baki, A., Szendrei, G. I., & Keserű, G. M. (2005) · Journal of Medicinal Chemistry · doi:10.1021/jm050504d · Cited by 73
Development of filter functions for protein–ligand docking
Ståhl, M., & Böhm, H. (1998) · Journal of Molecular Graphics and Modelling · doi:10.1016/s1093-3263(98)00018-7 · Cited by 72
Foloppe, N., Chen, I., Davis, B. J., Hold, A., Morley, D., & Howes, R. (2004) · Bioorganic & Medicinal Chemistry · doi:10.1016/j.bmc.2003.12.023 · Cited by 60
Self-citationFiltering databases and chemical libraries
Charifson, P. S., & Walters, W. P. (2002) · Journal of Computer-Aided Molecular Design · doi:10.1023/a:1020829519597 · Cited by 57
Foloppe, N., Fisher, L. M., Francis, G. L., Howes, R., Kierstan, P., & Potter, A. J. (2005) · Bioorganic & Medicinal Chemistry · doi:10.1016/j.bmc.2005.10.022 · Cited by 53
Self-citationBlocking CHK1 Expression Induces Apoptosis and Abrogates the G2 Checkpoint Mechanism
Luo, Y., Rockow-Magnone, S. K., Kroeger, P. E., Frost, L., Chen, Z., Han, E. K.-H., Ng, S., Simmer, R. L., & Giranda, V. L. (2001) · Neoplasia · doi:10.1038/sj.neo.7900175 · Cited by 51
Chk1 complements the G2/M checkpoint defect and radiosensitivity of ataxia-telangiectasia cells
Chen, P., Gatei, M. H., O’Connell, M. J., Khanna, K. K., Bugg, S. J., Hogg, A., Scott, S. P., Hobson, K., & Lavin, M. F. (1999) · Oncogene · doi:10.1038/sj.onc.1202257 · Cited by 43
Wang, G. T., Li, G., Mantei, R. A., Chen, Z., Kovar, P. J., Gu, W., Xiao, Z., Zhang, H., Sham, H. L., Sowin, T. J., et al. (2005) · Journal of Medicinal Chemistry · doi:10.1021/jm048989d · Cited by 43
Lin, N., Xia, P., Kovar, P. J., Park, C., Chen, Z., Zhang, H., Rosenberg, S. H., & Sham, H. L. (2005) · Bioorganic & Medicinal Chemistry Letters · doi:10.1016/j.bmcl.2005.09.064 · Cited by 42
Cited by
rDock: A Fast, Versatile and Open Source Program for Docking Ligands to Proteins and Nucleic Acids
Ruiz-Carmona, S., Alvarez-Garcia, D., Foloppe, N., Garmendia-Doval, A. B., Juhos, S., Schmidtke, P., Barril, X., Hubbard, R. E., & Morley, S. D. (2014) · PLoS Computational Biology · doi:10.1371/journal.pcbi.1003571 · Cited by 639
Self-citationDocking Screens for Novel Ligands Conferring New Biology: Miniperspective
Irwin, J. J., & Shoichet, B. K. (2016) · Journal of Medicinal Chemistry · doi:10.1021/acs.jmedchem.5b02008 · Cited by 277
Metadata
- Authors
- Foloppe, N., Fisher, L. M., Howes, R., Potter, A., Robertson, A. G. S., & Surgenor, A. E.
- Venue
- Bioorganic & Medicinal Chemistry
- Publisher
- Elsevier BV
- Published
- 2006-07
- Volume
- 14
- Issue
- 14
- Pages
- 4792-4802
- ISSN
- 0968-0896 (ISSN-L)
- OpenAlex
- W2093787075
- Cited by
- 363
- References
- 63
- FWCI
- 6.83
- Type
- journal article
- Language
- en
- Open access
- green
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.